Abstract
Mesenchymal neoplasms of the urinary bladder are exceedingly rare and display remarkable diversity. These tumors demonstrate distinct pathological features as well as variable biological behavior and cross-sectional imaging findings. The rarity of tumors, nonspecific symptoms and seemingly normal cystoscopic findings (particularly with small and exophytic tumors) frequently lead to misdiagnosis or missed diagnosis. While some tumors display characteristic cross-sectional imaging findings that may suggest a diagnosis, imaging findings are mostly nonspecific. Histopathological examination is required for accurate diagnosis, management and prognostication. The purpose of this article is to review the cross-sectional imaging findings of a diverse spectrum of mesenchymal tumors of the urinary bladder.
Graphical abstract
Similar content being viewed by others
References
Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, et al. Urinary Bladder Cancer: Role of MR Imaging. RadioGraphics. 2012;32(2):371-87.
Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006;26(2):553-80.
Chung AD, Schieda N, Flood TA, Cagiannos I, Kielar AZ, McInnes MD, et al. Suburothelial and extrinsic lesions of the urinary bladder: radiologic and pathologic features with emphasis on MR imaging. Abdom Imaging. 2015;40(7):2573-88.
Hatfield BS, Mochel MC, Smith SC. Mesenchymal Neoplasms of the Genitourinary System: A Selected Review with Recent Advances in Clinical, Diagnostic, and Molecular Findings. Surg Pathol Clin. 2018;11(4):837-76.
Tavora F, Kryvenko ON, Epstein JI. Mesenchymal tumours of the bladder and prostate: an update. Pathology. 2013;45(2):104-15.
Chmielecki J, Crago AM, Rosenberg M, O'Connor R, Walker SR, Ambrogio L, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013;45(2):131-2.
Huang SC, Huang HY. Solitary fibrous tumor: An evolving and unifying entity with unsettled issues. Histol Histopathol. 2019;34(4):313-34.
Mahajan P, Casanova M, Ferrari A, Fordham A, Trahair T, Venkatramani R. Inflammatory myofibroblastic tumor: molecular landscape, targeted therapeutics, and remaining challenges. Curr Probl Cancer. 2021;45(4):100768.
Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509-20.
Ahmadi H, Duddalwar V, Daneshmand S. Diagnosis and Staging of Bladder Cancer. Hematol Oncol Clin North Am. 2021;35(3):531-41.
Mirmomen SM, Shinagare AB, Williams KE, Silverman SG, Malayeri AA. Preoperative imaging for locoregional staging of bladder cancer. Abdom Radiol (NY). 2019;44(12):3843-57.
Katabathina VS, Rajebi H, Chen M, Restrepo CS, Salman U, Vikram R, et al. Genetics and imaging of pheochromocytomas and paragangliomas: current update. Abdom Radiol (NY). 2020;45(4):928-44.
Surabhi VR, Chua S, Patel RP, Takahashi N, Lalwani N, Prasad SR. Inflammatory Myofibroblastic Tumors: Current Update. Radiol Clin North Am. 2016;54(3):553-63.
Carrasquillo JA, Chen CC, Jha A, Ling A, Lin FI, Pryma DA, et al. Imaging of Pheochromocytoma and Paraganglioma. J Nucl Med. 2021;62(8):1033-42.
Helpap B. Nonepithelial neoplasms of the urinary bladder. Virchows Archiv. 2001;439(4):497-503.
Lu H, Male M, Jiang K, Ye Z, Song D, Xia D. Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder. Urol Oncol. 2019;37(6):354 e9- e17.
Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19(8):859–72.
Harik LR, Merino C, Coindre JM, Amin MB, Pedeutour F, Weiss SW. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am J Surg Pathol. 2006;30(7):787-94.
Hoekman K, van Doorn J, Gloudemans T, Maassen JA, Schuller AG, Pinedo HM. Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma. Clin Endocrinol (Oxf). 1999;51(2):247-53.
Lee TK, Miyamoto H, Osunkoya AO, Guo CC, Weiss SW, Epstein JI. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. Am J Surg Pathol. 2010;34(4):502-9.
Mouli S, Casalino DD, Nikolaidis P. Imaging features of common and uncommon bladder neoplasms. Radiol Clin North Am. 2012;50(2):301–16, vi.
Tanguay C, Harvey I, Houde M, Srigley JR, Tetu B. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases. Mod Pathol. 2003;16(5):512-4.
Zukerman Z, Schiavina R, Borghesi M, Brunocilla E, Vagnoni V, Pirini MG, et al. Smooth muscle tumor of uncertain malignant potential of the urinary bladder: a case report and review of the literature. Clin Genitourin Cancer. 2013;11(4):e6-9.
Keraliya AR, Tirumani SH, Shinagare AB, Zaheer A, Ramaiya NH. Solitary Fibrous Tumors: 2016 Imaging Update. Radiol Clin North Am. 2016;54(3):565-79.
Shanbhogue AK, Prasad SR, Takahashi N, Vikram R, Zaheer A, Sandrasegaran K. Somatic and visceral solitary fibrous tumors in the abdomen and pelvis: cross-sectional imaging spectrum. Radiographics. 2011;31(2):393-408.
Acosta AM, Demicco EG, Dal Cin P, Hirsch MS, Fletcher CDM, Jo VY. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions. Mod Pathol. 2021;34(2):469-77.
Shelmerdine SC, Lorenzo AJ, Gupta AA, Chavhan GB. Pearls and Pitfalls in Diagnosing Pediatric Urinary Bladder Masses. Radiographics. 2017;37(6):1872-91.
Tavora F, Montgomery E, Epstein JI. A series of vascular tumors and tumorlike lesions of the bladder. Am J Surg Pathol. 2008;32(8):1213-9.
Cheng L, Nascimento AG, Neumann RM, Nehra A, Cheville JC, Ramnani DM, et al. Hemangioma of the urinary bladder. Cancer. 1999;86(3):498-504.
Lee C, Kim B, Song B, Park JH, Moon KC. Clinicopathologic Features of Benign Neurogenic Tumor of Urinary Bladder. Int J Surg Pathol. 2018;26(3):221-8.
Cheng L, Scheithauer BW, Leibovich BC, Ramnani DM, Cheville JC, Bostwick DG. Neurofibroma of the urinary bladder. Cancer. 1999;86(3):505-13.
Kriegshauser JS, Conley CR, Hentz JG. Bladder wall fat on computed tomography with pathologic correlation. Clin Imaging. 2013;37(3):509-13.
Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol. 2010;41(1):1-15.
Prasad SR, Sahani DV, Mino-Kenudson M, Narra VR, Humphrey PA, Menias CO, et al. Neoplasms of the perivascular epithelioid cell involving the abdomen and the pelvis: cross-sectional imaging findings. J Comput Assist Tomogr. 2007;31(5):688-96.
Wu YL, Lang L, Ma Q, Wu F, Zhang Y, Chen W, et al. Perivascular Epithelioid Cell Tumor of Urinary Bladder. Am J Clin Pathol. 2021;156(1):56-71.
Neumann NM, Haffner MC, Argani P, Kao CS, Epstein JI. Histopathologic Characterization of Bladder Perivascular Epithelioid Cell Neoplasms (PEComa): A Series of 11 Cases With a Subset Having TFE3 Rearrangements. Am J Surg Pathol. 2021;45(2):169-77.
Williamson SR, Bunde PJ, Montironi R, Lopez-Beltran A, Zhang S, Wang M, et al. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features. Am J Surg Pathol. 2013;37(10):1619-26.
Xuesong D, Hong G, Weiguo Z. Bladder Perivascular Epithelioid Cell Tumor: Dynamic CT and MRI Presentation of 2 Cases With 2-year Follow-up and Review of the Literature. Clin Genitourin Cancer. 2019;17(5):e916-e22.
Tirumani SH, Shinagare AB, Hargreaves J, Jagannathan JP, Hornick JL, Wagner AJ, et al. Imaging features of primary and metastatic malignant perivascular epithelioid cell tumors. AJR Am J Roentgenol. 2014;202(2):252-8.
Crona J, Taieb D, Pacak K. New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification. Endocr Rev. 2017;38(6):489-515.
Sajjan RS, Gavra M, Agrawal K, Syed R, Bomanji J. 68Ga-DOTATATE PET/MR Imaging of Urinary Bladder Paraganglioma. Clin Nucl Med. 2015;40(8):692-4.
Roman-Gonzalez A, Jimenez C. Malignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials. Curr Opin Endocrinol Diabetes Obes. 2017;24(3):174-83.
Nguyen A, Fassas S, Freidberg N, Sullo E, Whalen M. Recurrence and treatment of adult primary nonmetastatic bladder rhabdomyosarcoma: A systematic review. Urol Oncol. 2021;39(11):774-80.
Nigro KG, MacLennan GT. Rhabdomyosarcoma of the bladder and prostate. J Urol. 2005;173(4):1365.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no relevant disclosures.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Balasubramanya, R., Shanbhogue, A.K., Ramani, N.S. et al. Mesenchymal neoplasms of the urinary bladder: a comprehensive review with focus on cross-sectional imaging findings. Abdom Radiol 47, 2881–2895 (2022). https://doi.org/10.1007/s00261-022-03568-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-022-03568-4